Drug Patent Expirations for the week of May 6, 2012
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| TRAVATAN Z | Alcon Pharms Ltd | travoprost | 6,503,497 | May 6, 2012 | |||||
| TRAVATAN Z | Alcon Pharms Ltd | travoprost | 6,849,253 | May 6, 2012 | |||||
| CRIXIVAN | Merck Sharp Dohme | indinavir sulfate | 5,413,999 | May 9, 2012 | |||||
| CHILDREN'S ALLEGRA ALLERGY | Sanofi Aventis Us | fexofenadine hydrochloride | 6,399,632 | May 11, 2012 | |||||
| CHILDREN'S ALLEGRA HIVES | Sanofi Aventis Us | fexofenadine hydrochloride | 6,399,632 | May 11, 2012 | |||||
| ALLEGRA | Sanofi Aventis Us | fexofenadine hydrochloride | 6,187,791 | May 11, 2012 | |||||
| CHILDREN'S ALLEGRA ALLERGY | Sanofi Aventis Us | fexofenadine hydrochloride | 6,187,791 | May 11, 2012 | |||||
| CHILDREN'S ALLEGRA HIVES | Sanofi Aventis Us | fexofenadine hydrochloride | 6,187,791 | May 11, 2012 | |||||
| ALLEGRA | Sanofi Aventis Us | fexofenadine hydrochloride | 6,399,632 | May 11, 2012 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
No comments:
Post a Comment